Published in J Infect Dis on September 01, 1974
Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev (1995) 1.90
Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev (1988) 1.78
Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A (1987) 1.63
Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. J Clin Invest (1981) 1.32
Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection. J Clin Invest (1980) 1.19
Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia. Clin Exp Immunol (1979) 1.18
Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. J Clin Microbiol (1986) 1.16
Detection of immunoglobulin M antibody to Epstein-Barr virus by use of an enzyme-labeled antigen. J Clin Microbiol (1982) 1.13
The immunology of Epstein-Barr virus infection. Philos Trans R Soc Lond B Biol Sci (2001) 1.04
Infectious mononucleosis and mononucleosis syndromes. West J Med (1977) 1.02
Improved immunofluorescence antigens for detection of immunoglobulin M antibodies to Epstein-Barr viral capsid antigen and antibodies to Epstein-Barr virus nuclear antigen. J Clin Microbiol (1982) 1.00
Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. J Clin Microbiol (1979) 0.98
Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis. J Clin Microbiol (1993) 0.91
A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency. Clin Exp Immunol (1986) 0.90
Herpesviruses. J Clin Pathol (1979) 0.89
Seroconversion to virus-specific pre-early nuclear antigens in infants with primary cytomegalovirus infection. Infect Immun (1980) 0.89
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies. Adv Virol (2012) 0.89
Detection of antibodies to Epstein-Barr virus capsid antigen by immune adherence hemagglutination. J Clin Microbiol (1982) 0.87
Immunotherapy targeting EBV-expressing lymphoproliferative diseases. Best Pract Res Clin Haematol (2008) 0.86
Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins. Can Med Assoc J (1976) 0.79
Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis. West J Med (1989) 0.78
Development of antibodies reactive in antibody-dependent cellular cytotoxicity in infectious mononucleosis. Infect Immun (1979) 0.77
Detection of antibodies to pre-early nuclear antigen and immediate-early antigens in patients immunized with cytomegalovirus vaccine. Infect Immun (1982) 0.75
Mononucleosis syndrome and coincidental human herpesvirus-7 and Epstein-Barr virus infection. Arch Dis Child (1998) 0.75
Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors. J Immunother (2016) 0.75
Immunocytochemical detection of antibodies to Epstein-Barr virus nuclear antigen by a streptavidin-biotin-complex assay. J Clin Microbiol (1988) 0.75
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
INTERFERENCE OF INACTIVE VIRUS WITH THE PROPAGATION OF VIRUS OF INFLUENZA. Science (1943) 10.31
Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A (1968) 8.67
Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science (1967) 8.62
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science (1970) 7.60
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : I. THE DISPERSION OF THE VIRUS OF INFLUENZA A IN TISSUE EMULSIONS AND IN EXTRA-EMBRYONIC FLUIDS OF THE CHICK. J Exp Med (1943) 4.30
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA (1968) 4.26
Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst (1966) 4.19
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
NEUROLOGICAL SIGNS IN MICE FOLLOWING INTRACEREBRAL INOCULATION OF INFLUENZA VIRUSES. Science (1944) 3.61
Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol (1974) 3.58
Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer (1976) 3.36
High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A (1985) 3.35
THE EFFECT OF VITAMIN B(1) DEFICIENCY AND OF RESTRICTED FOOD INTAKE ON THE RESPONSE OF MICE TO THE LANSING STRAIN OF POLIOMYELITIS VIRUS. J Exp Med (1944) 3.17
SEROLOGICAL SPECIFICITY OF HEAVY PARTICLES DERIVED FROM NORMAL ORGANS. Science (1940) 3.12
Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol (1968) 3.09
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07
Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis (1975) 3.02
Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01
Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer (1971) 3.00
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
STUDIES ON THE COMPLEMENT FIXATION ANTIGENS OF INFLUENZA VIRUSES TYPES A AND B. J Exp Med (1946) 2.50
Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells. J Bacteriol (1966) 2.42
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci U S A (1986) 2.34
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : II. THE SIZE OF THE INFECTIOUS UNIT IN INFLUENZA A. J Exp Med (1943) 2.24
Fine structure of a virus in cultured lymphoblasts from Burkitt lymphoma. J Bacteriol (1966) 2.15
Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol (1966) 2.10
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines. Cancer Res (1967) 2.05
Replication of mumps virus in human leukocyte cultures. J Bacteriol (1966) 2.03
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
RELATION OF FOOD INTAKE TO RESPONSE OF MICE INOCULATED WITH LANSING STRAIN OF MURINE POLIOMYELITIS VIRUS. Science (1943) 1.94
Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses. J Exp Med (1977) 1.90
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83
Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer (1978) 1.77
Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol (1985) 1.76
Fatal infectious mononucleosis in a family. N Engl J Med (1974) 1.73
Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol (1969) 1.68
Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A (1987) 1.63
Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest (1981) 1.63
Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int J Cancer (1974) 1.62
Epstein-Barr virus and infectious mononucleosis. N Engl J Med (1973) 1.60
Studies on cell lines derived from Burkitt's lymphoma. Trans N Y Acad Sci (1966) 1.60
A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr (1982) 1.60
Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int J Cancer (1977) 1.58
Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer (1970) 1.57
Incidence of heterophil antibody responses in children with infectious mononucleosis. J Pediatr (1979) 1.55
Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis (1970) 1.50
Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clin Exp Immunol (1979) 1.50
An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. J Immunol (1983) 1.49
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer (1987) 1.48
Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments. J Virol (1981) 1.48
Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis (1971) 1.48
Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med (1986) 1.48
Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis (1985) 1.43
Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res (1981) 1.43
Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors. J Natl Cancer Inst (1973) 1.43
C-group chromosome marker in long-term leukocyte cultures. J Natl Cancer Inst (1968) 1.43
Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst (1971) 1.43
Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer (1978) 1.43
Observations on childhood infections with the Epstein-Barr virus. J Infect Dis (1970) 1.39
Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) (1986) 1.38
Heterophil antigen in bovine sera detectable by immune adherence hemagglutination with infectious mononucleosis sera. Infect Immun (1978) 1.35
Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med (1988) 1.35
Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis (1975) 1.35
Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol (1975) 1.35
The Epstein-Barr virus. Sci Am (1979) 1.34
Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells. J Virol (1968) 1.33
False negative and prozone reactions in tests for antibodies to Epstein-Barr virus-associated nuclear antigen. Int J Cancer (1974) 1.33
Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med (1975) 1.30
Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer (1980) 1.29
Production of antigens associated with Epstein-Barr virus in experimentally infected lymphoblastoid cell lines. J Natl Cancer Inst (1971) 1.28
Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence. J Exp Med (1969) 1.26
THE TOXICITY OF INFLUENZA VIRUSES. Science (1945) 1.26
Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus. Int J Cancer (1978) 1.25
The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol (1990) 1.23
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Autogenous and virus-induced interferons from lines of lymphoblastoid cells. Cancer Res (1969) 1.23
Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature (1970) 1.22
Persistent falsely positive rapid tests for infectious mononucleosis. Report of five cases with four--six-year follow-up data. Am J Clin Pathol (1979) 1.21
Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. N Engl J Med (1970) 1.21
Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis (1979) 1.19
Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. Br J Cancer (1982) 1.18
Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia. Clin Exp Immunol (1979) 1.18
Detection of infectious mononucleosis heterophil antibody by a rapid, standardized enzyme-linked immunosorbent assay procedure. J Clin Microbiol (1982) 1.18
Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int J Cancer (1977) 1.16
Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1980) 1.15
STUDIES ON THE TOXICITY OF INFLUENZA VIRUSES : I. THE EFFECT OF INTRACEREBRAL INJECTION OF INFLUENZA VIRUSES. J Exp Med (1946) 1.15